Deborah M Siegal, Joshua O Cerasuolo, Marc Carrier, Peter L Gross, Moira K Kapral, David Kirkwood, Ronda Lun, Michel Shamy, Rinku Sutradhar
{"title":"Risk of ischemic stroke after cancer diagnosis: a population-based matched cohort study.","authors":"Deborah M Siegal, Joshua O Cerasuolo, Marc Carrier, Peter L Gross, Moira K Kapral, David Kirkwood, Ronda Lun, Michel Shamy, Rinku Sutradhar","doi":"10.1016/j.jtha.2024.12.029","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There are limited data regarding the association between cancer and ischemic stroke, particularly among individuals with previous stroke. Our objective was to measure and compare the risk of ischemic stroke in individuals with and without cancer.</p><p><strong>Methods: </strong>Population-based matched cohort study in Ontario, Canada. Participants ≥18 years with a new diagnosis of cancer were matched (1:1) to cancer-free controls by age and sex in two separate matched cohorts based on the absence (Matched Cohort 1) or presence (Matched Cohort 2) of prior ischemic stroke. The primary outcome was the incidence of ischemic stroke. We calculated sub-distribution adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for ischemic stroke (death as a competing event).</p><p><strong>Results: </strong>In Matched Cohort 1, the rate and risk of ischemic stroke were higher among 620,647 cancer patients versus 620,647 controls at 1.5 years (4.6/1000 person-years [95%CI 4.5-4.7] vs 3.5/1000 person-years [95%CI 3.4-3.6], aHR 1.40, 95%CI 1.34-1.47). In Matched Cohort 2, the rate and risk of ischemic stroke were similar among 13,924 cancer patients and 13,924 controls at 1.5 years (26.9/1000 person-years [95%CI 25.1-28.9] vs 22.0 /1000 person-years [95/%CI 20.7-23.4]; aHR 1.00, 95%CI 0.88-1.14). In both cohorts, the risk of ischemic stroke was lower in cancer patients versus controls from 1.5 to 5 years (aHR 0.72, 95%CI 0.69-0.74 and aHR 0.53, 95%CI 0.46-0.62).</p><p><strong>Conclusions: </strong>Compared to cancer-free controls, the rate and risk of ischemic stroke were higher 1.5 years after cancer diagnosis in individuals without prior stroke and varied according to cancer site and stage.</p>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":" ","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtha.2024.12.029","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: There are limited data regarding the association between cancer and ischemic stroke, particularly among individuals with previous stroke. Our objective was to measure and compare the risk of ischemic stroke in individuals with and without cancer.
Methods: Population-based matched cohort study in Ontario, Canada. Participants ≥18 years with a new diagnosis of cancer were matched (1:1) to cancer-free controls by age and sex in two separate matched cohorts based on the absence (Matched Cohort 1) or presence (Matched Cohort 2) of prior ischemic stroke. The primary outcome was the incidence of ischemic stroke. We calculated sub-distribution adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for ischemic stroke (death as a competing event).
Results: In Matched Cohort 1, the rate and risk of ischemic stroke were higher among 620,647 cancer patients versus 620,647 controls at 1.5 years (4.6/1000 person-years [95%CI 4.5-4.7] vs 3.5/1000 person-years [95%CI 3.4-3.6], aHR 1.40, 95%CI 1.34-1.47). In Matched Cohort 2, the rate and risk of ischemic stroke were similar among 13,924 cancer patients and 13,924 controls at 1.5 years (26.9/1000 person-years [95%CI 25.1-28.9] vs 22.0 /1000 person-years [95/%CI 20.7-23.4]; aHR 1.00, 95%CI 0.88-1.14). In both cohorts, the risk of ischemic stroke was lower in cancer patients versus controls from 1.5 to 5 years (aHR 0.72, 95%CI 0.69-0.74 and aHR 0.53, 95%CI 0.46-0.62).
Conclusions: Compared to cancer-free controls, the rate and risk of ischemic stroke were higher 1.5 years after cancer diagnosis in individuals without prior stroke and varied according to cancer site and stage.
期刊介绍:
The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community.
Types of Publications:
The journal publishes a variety of content, including:
Original research reports
State-of-the-art reviews
Brief reports
Case reports
Invited commentaries on publications in the Journal
Forum articles
Correspondence
Announcements
Scope of Contributions:
Editors invite contributions from both fundamental and clinical domains. These include:
Basic manuscripts on blood coagulation and fibrinolysis
Studies on proteins and reactions related to thrombosis and haemostasis
Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms
Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases
Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.